Modulation of gene methylation by genistein or lycopene in breast cancer cells
Article first published online: 7 JAN 2008
Copyright © 2008 Wiley-Liss, Inc.
Environmental and Molecular Mutagenesis
Volume 49, Issue 1, pages 36–45, January 2008
How to Cite
King-Batoon, A., Leszczynska, J. M. and Klein, C. B. (2008), Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ. Mol. Mutagen., 49: 36–45. doi: 10.1002/em.20363
- Issue published online: 14 JAN 2008
- Article first published online: 7 JAN 2008
- Manuscript Accepted: 21 NOV 2007
- Manuscript Revised: 19 NOV 2007
- Manuscript Received: 16 OCT 2007
- Susan G. Komen Breast Cancer Foundation. Grant Number: BCTR0402531
- NYU/NIEHS Center. Grant Number: ES000260
- NYU Cancer Center. Grant Number: CA016087
- NIEHS. Grant Number: T32 ES007324
- 2002. Phytoestrogens and cancer. Lancet Oncol 3: 364–373. .
- 2006. Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers. Breast Cancer Res Treat 100: 169–176. , , , , , .
- 2007. Mechanisms underlying prevention of genomic instability in breast tumor cells by genistein and lycopene. Environ Mol Mutagen 48: 618 Abs. P116. , , .
- 2005. Carotenoids activate the antioxidant response element transcription system. Mol Cancer Ther 4: 177–186. , , , , , , , , .
- 2001. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas. Cancer Genet Cytogenet 125: 131–138. , , , , , , .
- 2002. Safety and pharmacokinetics of purified soy isoflavones: Single-dose administration to postmenopausal women. Am J Clin Nutr 76: 1126–1137. , , , , , , , , , , .
- 2002. Diet and breast cancer. Ann N Y Acad Sci 963: 247–267. , .
- 1978. Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization. In Vitro 14: 911–915. , , .
- 1993. Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14: 483–492. , .
- 2006. Gene signature of breast cancer cell lines treated with lycopene. Pharmacogenomics 7: 663–672. , , , , , .
- 2007a. Expression profiling by whole-genome microarray hybridization reveals differential gene expression in breast cancer cell lines after lycopene exposure. Biochim Biophys Acta 1769: 124–130. , , , , .
- 2007b. Immunohistochemical expression of RARα, RARβ, and Cx43 in breast tumor cell lines after treatment with lycopene and correlation with RT-QPCR. J Histochem Cytochem 55: 877–883. , , , , , .
- 2000. Mass spectrometric determination of genistein tissue distribution in diet-exposed Sprague-Dawley rats. J Nutr 130: 1963–1970. , , , , .
- 2005. Molecular characterization of the t(3;9) associated with immortalization in the MCF10A cell line. Cancer Genet Cytogenet 163: 23–29. , , , , , .
- 2007. Dietary components impact histone modifications and cancer risk. Nutr Rev 65: 88–94. , .
- 2001. Dietary genistein increased DMBA-induced mammary adenocarcinomas in wild-type, but not ER alpha KO, mice. Nutr Cancer 39: 226–232. , , , , , .
- 2002. Genistein alters methylation patterns in mice. J Nutr 132: 2419S–2423S. , , , , , , , , , , , .
- 2001. Multiple points of intervention in the prevention of cancer and other mutation-related diseases. Mutat Res 480–481: 9–22. , , , , , .
- 1989. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274: 532–538. , , .
- 2006. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 114: 567–572. , , , .
- 2006. Tomatoes, tomato products and lycopene in the prevention and treatment of prostate cancer: Do we have the evidence from intervention studies? Curr Opin Clin Nutr Metab Care 9: 722–727. , , .
- 1998. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 58: 4515–4518. , , , , , .
- 2007. Dietary polyphenols may affect DNA methylation. J Nutr 137: 223S–228S. , , .
- 2005. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 11: 7033–7041. , , , , , .
- 2002. Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells. Cell Growth Differ 13: 335–341. , , , , , .
- 2004. Dietary cancer and prevention using antimutagens. Toxicology 198: 147–159. , , .
- 1997. Cancer prevention by organosulfur compounds from garlic and onion. J Cell Biochem 27: 100–105. , , , .
- 2007. The DNA-binding epidermal growth factor-receptor inhibitor PD153035 and other DNA-intercalating cytotoxic drugs reactivate the expression of the retinoic acid receptor-beta tumor-suppressor gene in breast cancer cells. Differentiation 75: 883–890. , , , , .
- 1996. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821–9826. , , , , .
- 1999. Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. Oncol Rep 6: 1089–1095. , , , , .
- 2007. Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells. Breast Cancer Res Treat 104: 221–230. , , , , .
- 2001. Phytoestrogen consumption and breast cancer risk in a multiethnic population: The Bay Area Breast Cancer Study. Am J Epidemiol 154: 434–441. , , , , , , , , , .
- 1998. Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells. Gene 210: 1–7. , .
- 2000. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 36: 101–111. , , , , , , , , , .
- 2007. The U.S. Food and Drug Administration's evidence-based review for qualified health claims: Tomatoes, lycopene, and cancer. J Natl Cancer Inst 99: 1074–1085. , , .
- 2004. Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 79: 282–288. , , , .
- 2006. Prevention of spontaneous and X-ray induced genomic instability in breast cancer cells by the dietary antimutagens genistein and lycopene. Environ Mol Mutagen 47: 425. , , , .
- 2007. Antimutagenicity of cinnamaldehyde and vanillin in human cells: Global gene expression and possible role of DNA damage and repair. Mutat Res 616: 60–69. , , , , , , , , , .
- 2007. Genistein genotoxicity: Critical considerations of in vitro exposure dose. Toxicol Appl Pharmacol 224: 1–11. , .
- 2005. HIN-1, an inhibitor of cell growth, invasion, and AKT activation. Cancer Res 65: 9659–9669. , , , , , , , , , .
- 2006. Colorectal cancer protective effects and the dietary micronutrients folate, methionine, vitamins B6, B12, C, E, selenium, and lycopene. Nutr Cancer 56: 11–21. , .
- 2000. Protection against breast cancer with genistein: A component of soy. Am J Clin Nutr 7: 1705S–1707S. .
- 2007. GSTP1 promoter hypermethylation is an early event in breast carcinogenesis. Virchows Arch 450: 637–642. .
- 2005. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol 68: 1018–1030. , , .
- 2004. Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome. Clin Cancer Res 10: 1338–1343. , , , , , , , , .
- 1999. Plasma lycopene concentrations in humans are determined by lycopene intake, plasma cholesterol concentrations and selected demographic factors. J Nutr 129: 849–854. , , , , , , , , , .
- 2004. Low plasma lycopene concentration is associated with increased mortality in a cohort of patients with prior oral, pharynx, and larynx cancers. J Am Coll Nutr 23: 34–42. , , , , .
- 2001. Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis. Adv Exp Med Biol 492: 69–81. .
- 2003. Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer. Am J Clin Nutr 77: 875–882. , , , , , , , , , .
- 1997. Comparative mechanisms and rates of free radical scavenging by carotenoid antioxidants. FEBS Lett 418: 91–97. , , , , .
- 2001. Reduction of spontaneous mutagenesis in mismatch repair-deficient and proficient cells by dietary antioxidants. Mutat Res 480–481: 85–95. , .
- 2006. Analysis of the ability of individual isofavones in soybean-processing by-product mixtures to reduce spontaneous mutation in mismatch-repair deficient cells. Environ Mol Mutagen 47:Abs. P134. , , , , .
- 2004. A novel mechanism of chemoprotection by sulforaphane: Inhibition of histone deacetylase. Cancer Res 64: 5767–5774. , , , .
- 2006. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis 27: 811–819. , , , , .
- 2007. Structural influence of isothiocyanates on the antioxidant response element (ARE)-mediated heme oxygenase-1 (HO-1) expression. Pharm Res [Epub ahead of print]. , , , , , , , .
- 2007. Carotenoids and human health. Pharmacol Res 55: 207–216. , .
- 2003. A model to estimate the oestrogen receptor mediated effects from exposure to soy isoflavones in food. Regul Toxicol Pharmacol 38: 196–209. , , , , , .
- 2003. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy. Clin Cancer Res 9: 1596–1603. , , , , , , , , , .
- 2006. Genistein suppresses proliferation and MET oncogene expression and induces EGR-1 tumor suppressor expression in immortalized human breast epithelial cells. Anticancer Res 26: 1039–1048. , .
- 2002. Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer. Cancer Res 62: 2455–2461. , , , , , , , , .
- 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50: 6075–6086. , , , , , , , , , .
- 2007. Plasma and dietary carotenoids are associated with reduced oxidative stress in women previously treated for breast cancer. Cancer Epidemiol Biomarkers Prev 16: 2008–2015. , , , , , .
- 2005. Plasma carotenoids, retinol, and tocopherols and risk of breast cancer. Am J Epidemiol 161: 153–160. , , , , , , , .
- 2003. Isoflavone intake in four different European countries: The VENUS approach. Br J Nutr 89: 25–30. , , .
- 2000. Diet and apoptosis. Annu Rev Nutr 20: 485–505. , , .
- 1997. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res 57: 4158–4161. , , , , , , , .
- 2000. Methylation and silencing of the retinoic acid receptor-β2 gene in breast cancer. J Natl Cancer Inst 92: 826–832. , , , , , , , , , , .
- 2001. Epigenetic downregulation of the retinoic acid receptor-β2 gene in breast cancer. J Mammary Gland Biol Neoplasia 6: 193–201. , , , , .
- 2004. Influence of 10 wk soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora in healthy adults. Am J Clin Nutr 80: 692–699. , , , , , , , , , .
- 2002. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23: 1491–1496. , , , , , .
- 1995. Diet and breast cancer in Shanghai and Tianjin, China. Br J Cancer 71: 1353–1358. , , , , .
- 1993. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85: 1819–1827. , , , , , , , , , , .
- 1999. Urinary disposition of the soybean isoflavones daidzein, genistein, and glycitein differs among humans with moderate fecal isoflavone degradation activity. J Nutr 129: 957–962. , , , , .
- 2001. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 61: 249–255. , , , , , .